版本:
中国

BRIEF-Aptevo Therapeutics reports Q1 loss per share $0.48

May 12 Aptevo Therapeutics Inc

* Aptevo Therapeutics reports first quarter 2017 financial results

* Q1 loss per share $0.48

* Aptevo Therapeutics Inc - total product sales revenue was $7.4 million for first three months ended march 31, 2017, compared to $7.9 million

* Aptevo Therapeutics Inc - Aptevo and midcap financial trust agreed to amend a credit agreement initially executed in august 2016

* Aptevo Therapeutics Inc - amendment extends time period through which company can draw second tranche from august 2017 to march 2018

* Aptevo Therapeutics - amendment modifies minimum net commercial product revenue requirements which co is required to achieve on a rolling twelve-month basis

* Aptevo Therapeutics Inc - amendment increases exit fee from 5.75 percent for repayment or prepayment to 6.75 percent Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐